Stem cell therapy has become the newest player in the quest to slow the aging process. “It’s a fantastic tool,” says Dr. Chadwick C. Prodromos, who heads an institute that offers stem cell injections and conducts extensive research into the role stem cells can play in treating a variety of medical conditions. Stem cell infusions — which do not require surgery — have proven successful, according to Dr. Prodromos, in countering short-term memory loss, brain fog and fatigue. Those conditions “diminish substantially,” after the injections, he reports. Stem cells, however, have not proven effective in treating Alzheimer’s disease. “Maybe some day,” the orthopedic surgeon says, “but not right now.” Because the U.S. Food and Drug Administration has not yet approved this form of stem cell therapy, it is not available in the United States. But Dr. Prodromos’s institute, which is based in Chicago, offers the treatment in a number of other countries, including Mexico, Argentina and Antigua. The Prodromos Stem Cell Institute began by treating patients with neurological disorders like spinal cord injuries, strokes, and cerebral palsy, and got “people out of their wheelchairs,” Dr. Prodromos says. They then adapted the process for anti-aging “not just for people with serious problems, but for people who want to, I hate to use the word, but rejuvenate their heart or their brain.” Dr. Prodromos says he uses adult rather than embryonic stem cells. The therapy thus does not raise ethical concerns once claimed by abortion foes over fetal stem cells. Learn more about Dr. Prodromos's ideas and programs for prolonging life and the Prodromos Stem Cell Institute at https://www.thepsci.com/ ***** Dr. Chadwick C. Prodromos, director of the Prodromos Stem Cell Institute (PSCI), is an international leader in the use of stem cell and platelet rich plasma treatments. He received his bachelor’s degree with honors from Princeton University and his MD from the Johns Hopkins Medical School. He served his surgical internship at the University of Chicago, his orthopedic surgery residency at Rush University and his fellowship in orthopedics and sports medicine at the Harvard Medical School and Massachusetts General Hospital. He is board certified in orthopedic surgery and is editor of a major textbook for orthopedic surgeons on the ACL. Dr. Prodromos was an assistant professor of orthopedic surgery at Rush University for 27 years before leaving to focus on his foundation and stem cell work. He is also medical director of “The FOREM” (The Foundation for Regenerative Medicine), which supports ongoing prospective studies of the more than 4,000 biologic treatments he and his staff have performed. The continued follow-up, research and data collection distinguishes the PSCI from other clinics in the field. ***** Thank you to our Cutting Edge Health supporters: CZTL Methylene Blue Get a $10 discount by using this link: https://cztl.bz?ref=3OqY9 on an order of $70 or more OR use this discount code at checkout: jane10 Renue by Science: 10% off NMN https://renuebyscience.com/product/pure-nmn-sublingual-powder-30-grams/ Enter jane10 at checkout for 10% off. Cutting Edge Health podcast website: https://cuttingedgehealth.com/ Cutting Edge Health Social and YouTube: YouTube channel: youtube.com/@cuttingedgehealthpodcast Instagram - https://instagram.com/cuttingedgehealthpodcast Facebook - https://www.facebook.com/Cutting-Edge-Health-Podcast-with-Jane-Rogers-101036902255756 Please note that the information provided in this show is not medical advice, nor should it be taken or applied as a replacement for medical advice. The Cutting Edge Health podcast, its employees, guests and affiliates assume no liability for the application of the information discussed. Special thanks to Alan, Maria, Louis, and Nicole on the Cutting Edge Health team!

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related